Skip to content

Oric Pharmaceuticals

US · ORIC #3089 by market cap Listed 2020
7.36 -0.34 -4.42%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C+
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 23.57 +220.2%
Price target rangecurrent 7.36
Low18.00
Avg23.57
High27.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-29 Stifel -- Buy 18.00
2026-10-27 Cantor Fitzgerald -- Buy --
2026-10-27 JonesTrading -- Buy 25.00
2026-10-27 BTIG -- Buy 26.00
2026-10-27 H.C. Wainwright -- Buy 27.00
2026-10-26 Stifel -- Buy 18.00
2026-10-25 BTIG -- Buy 26.00
2026-10-23 JonesTrading -- Buy 25.00
2026-10-21 Guggenheim -- Buy 18.00
2026-10-18 BTIG -- Buy 26.00
2026-10-16 Wells Fargo -- Buy 25.00
2026-10-14 J.P. Morgan -- Buy 26.00
2026-09-23 BTIG -- Buy 26.00
2026-08-10 H.C. Wainwright -- Buy 27.00
2026-08-06 J.P. Morgan -- Buy 23.00
2026-08-04 Wells Fargo -- Buy 25.00
2026-08-04 JonesTrading -- Buy 25.00
2026-08-04 Piper Sandler -- Buy 22.00
2026-08-04 Evercore -- Buy 25.00
2026-08-04 Stifel -- Buy 14.00
2026-08-03 Guggenheim -- Buy 18.00
2026-06-29 Piper Sandler -- Buy 22.00
2026-06-24 H.C. Wainwright -- Buy 25.00
2026-06-12 Stifel -- Buy 14.00
2026-06-11 Wells Fargo -- Buy 25.00

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionActual move
2021/Q4 2022-03-21 After close -28.74%
2020/Q2 2020-08-05 After close +14.07%

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Oric Pharmaceuticals discussion 0 comments

Add a comment